BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 681167)

  • 21. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pituitary hormonal reserve in patients presenting hyperprolactinemia, intrasellar masses, and amenorrhea without galactorrhea.
    Zarate A; Canales ES; Villalobos H; Soria J; Jacobs LS; Kastin AJ; Schally AV
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1034-7. PubMed ID: 805793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nocturnal melatonin and luteinizing hormone rhythms in women with hyperprolactinemic amenorrhea.
    Luboshitzky R; Lavi S; Thuma I; Lavie P
    J Pineal Res; 1996 Mar; 20(2):72-8. PubMed ID: 8815190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of pulsatile liberation of gonadotropins in the development of amenorrhea].
    Hámori M; Szendei G; Urbancsek J
    Zentralbl Gynakol; 1987; 109(12):783-7. PubMed ID: 3115000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular heterogeneity of prolactin and gonadotropins in some forms of sterility].
    Morán C; Fonseca ME; Ochoa R; Masón M; Gama R; Zárate A
    Ginecol Obstet Mex; 1990; 58 Suppl 1():9-13. PubMed ID: 2125965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary and ovarian response patterns to stimulation in the postpartum and in galactorrhea-amenorrhea. The role of prolactin.
    del Pozo E; Varga L; Schulz KD; Künzig HJ; Marbach P; del Campo GL; Eppenberger U
    Obstet Gynecol; 1975 Nov; 46(5):539-43. PubMed ID: 1105275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rational hormonal diagnosis of oligomenorrhea].
    Weise HC; Moltz L; Bispink G; Leidenberger F
    Geburtshilfe Frauenheilkd; 1989 Aug; 49(8):694-700. PubMed ID: 2529165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of endocrinologic diagnosis in sterility patients. A clinical report of experiences].
    Melzer H; Uhlmann G
    Zentralbl Gynakol; 1985; 107(16):989-95. PubMed ID: 3931388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary hypothyroidism presenting with amenorrhea, galactorrhea, hyperprolactinemia and enlarged pituitary].
    Tadmor OP; Barr I; Diamant YZ
    Harefuah; 1992 Jan; 122(2):76-8. PubMed ID: 1572562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolactin-secreting pituitary adenomas in women. II. Menstrual function, pituitary reserves, and prolactin production following microsurgical removal.
    Keye WR; Chang RJ; Monroe SE; Wilson CB; Jaffe RB
    Am J Obstet Gynecol; 1979 Jun; 134(4):360-5. PubMed ID: 222148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pseudocyesis: clinical and hormonal evaluation].
    Meza E; Choy J; Villanueva C; Ayala A
    Ginecol Obstet Mex; 1989 Nov; 57():308-10. PubMed ID: 2518625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.
    Hochner-Celnikier D; Zylber-Haran E; Shilo S; Palti Z; Spitz IM
    Obstet Gynecol; 1982 Mar; 59(3):280-4. PubMed ID: 6804899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
    Quigley ME; Judd SJ; Gilliland GB; Yen SS
    J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyperprolactinemic ovarian insufficiency].
    Schneider HP; Bohnet HG
    Gynakologe; 1981 Jun; 14(2):104-18. PubMed ID: 6790354
    [No Abstract]   [Full Text] [Related]  

  • 38. Galactorrhea-amenorrhea and hyperprolactinemia associated with pituitary tumors of growth-hormone- and adrenocorticotropic-hormone-secreting cells. A report of two cases.
    Haney AF; McCarty KS; Hammond CB
    J Reprod Med; 1984 Dec; 29(12):883-7. PubMed ID: 6097688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Yellow body function in bromocryptine induced early pregnancy in patients with hyperprolactinemia (author's transl)].
    Smiljanić N; Ciglar S; Podobnik M
    Jugosl Ginekol Opstet; 1981; 21(3-4):65-9. PubMed ID: 6803072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
    Jacobs HS; Franks S; Murray MA; Hull MG; Steele SJ; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):439-54. PubMed ID: 825329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.